Moni M, Sathyapalan D, Edathadathil F, Razak M, Nair S, Nair C
Open Forum Infect Dis. 2024; 11(7):ofae406.
PMID: 39070046
PMC: 11273325.
DOI: 10.1093/ofid/ofae406.
van Grootveld R, van Paassen J, Claas E, Heerdink L, Kuijper E, de Boer M
Med Mycol. 2024; 62(5).
PMID: 38544330
PMC: 11095538.
DOI: 10.1093/mmy/myae028.
Casutt A, Lamoth F, Lortholary O, Prior J, Tonglet A, Manuel O
Eur Respir Rev. 2023; 32(169).
PMID: 37758271
PMC: 10523149.
DOI: 10.1183/16000617.0086-2023.
Ouranos K, Tsakiri K, Massa E, Dourliou V, Mouratidou C, Soundoulounaki S
Ann Thorac Med. 2023; 18(3):116-123.
PMID: 37663880
PMC: 10473063.
DOI: 10.4103/atm.atm_14_23.
Beltrame A, Stevens D, Haiduven D
J Fungi (Basel). 2023; 9(6).
PMID: 37367625
PMC: 10305703.
DOI: 10.3390/jof9060689.
Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments.
Singh R, Malik P, Kumar M, Kumar R, Alam M, Mukherjee T
Pharmacol Rep. 2023; 75(4):817-837.
PMID: 37354313
DOI: 10.1007/s43440-023-00506-z.
A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
Sanchez-Castellano M, Marcelo C, Marco J, Figueira-Iglesias J, Garcia-Rodriguez J
Mycopathologia. 2023; 188(4):335-344.
PMID: 37256502
PMC: 10230482.
DOI: 10.1007/s11046-023-00750-0.
Recurrent Hydropneumothorax After COVID-19.
Patel V, Patel S, Singletary K, Pacheco L
Cureus. 2023; 15(3):e36208.
PMID: 36937124
PMC: 10017555.
DOI: 10.7759/cureus.36208.
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F, Calandra T
Eur Respir Rev. 2022; 31(166).
PMID: 36450372
PMC: 9724826.
DOI: 10.1183/16000617.0114-2022.
-SARS-CoV-2 Coinfection: What Is Known?.
Castro-Fuentes C, Reyes-Montes M, Frias-De-Leon M, Valencia-Ledezma O, Acosta-Altamirano G, Duarte-Escalante E
Pathogens. 2022; 11(11).
PMID: 36364979
PMC: 9694759.
DOI: 10.3390/pathogens11111227.
The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance.
Poissy J, Rouze A, Cornu M, Nseir S, Sendid B
J Fungi (Basel). 2022; 8(9).
PMID: 36135671
PMC: 9500670.
DOI: 10.3390/jof8090946.
Overview of COVID-19-Associated Invasive Fungal Infection.
Shishido A, Mathew M, Baddley J
Curr Fungal Infect Rep. 2022; 16(3):87-97.
PMID: 35846240
PMC: 9274633.
DOI: 10.1007/s12281-022-00434-0.
Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients.
Baten N, Wajed S, Talukder A, Masum M, Rahman M
Beni Suef Univ J Basic Appl Sci. 2022; 11(1):64.
PMID: 35529527
PMC: 9066134.
DOI: 10.1186/s43088-022-00245-9.
Increased incidence of candidemia in critically ill patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
Papadimitriou-Olivgeris M, Kolonitsiou F, Kefala S, Spiliopoulou A, Aretha D, Bartzavali C
Braz J Infect Dis. 2022; 26(2):102353.
PMID: 35500645
PMC: 9035354.
DOI: 10.1016/j.bjid.2022.102353.
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions.
Egger M, Bussini L, Hoenigl M, Bartoletti M
J Fungi (Basel). 2022; 8(4).
PMID: 35448621
PMC: 9027069.
DOI: 10.3390/jof8040390.
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate.
Clancy C, Nguyen M
Open Forum Infect Dis. 2022; 9(5):ofac081.
PMID: 35386295
PMC: 8903513.
DOI: 10.1093/ofid/ofac081.
Routine Surveillance of Healthcare-Associated Infections Misses a Significant Proportion of Invasive Aspergillosis in Patients with Severe COVID-19.
Ebner J, Van den Nest M, Bouvier-Azula L, Fuszl A, Gabler C, Willinger B
J Fungi (Basel). 2022; 8(3).
PMID: 35330275
PMC: 8954197.
DOI: 10.3390/jof8030273.
COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
Calderon-Parra J, Mills-Sanchez P, Moreno-Torres V, Tejado-Bravo S, Romero-Sanchez I, Balandin-Moreno B
Mycoses. 2022; 65(5):541-550.
PMID: 35212030
PMC: 9115267.
DOI: 10.1111/myc.13434.
The Continuing Emergence of as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2.
Mirchin R, Czeresnia J, Orner E, Chaturvedi S, Murphy K, Nosanchuk J
J Fungi (Basel). 2022; 8(2).
PMID: 35205920
PMC: 8878287.
DOI: 10.3390/jof8020166.
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
Lackner N, Thome C, Ofner D, Joannidis M, Mayerhofer T, Arora R
J Fungi (Basel). 2022; 8(2).
PMID: 35205848
PMC: 8875712.
DOI: 10.3390/jof8020093.
